Navigation Links
Measuring Pain from the Patient's Point of View
Date:9/21/2009

LINCOLN, R.I., Sept. 21 /PRNewswire/ -- According to the National Centers for Health Statistics, 76.2 million Americans report problems with chronic pain; more than diabetes, heart disease, and cancer combined. The same report notes that the annual cost of chronic pain in the United States, including healthcare expenses, lost income, and productivity, is estimated to be $100 billion.

"Despite the obvious impact on our society and economy, pain can be difficult to measure. There are many variables such as the association of pain with multiple conditions and the lack of a standardized metric for measuring the impact of pain on an individual's daily life," says Gus Gardner, President and Chief Operating Officer at QualityMetric Incorporated. "Recently, we've noticed a marked increase in our customer's desire to measure pain accurately and efficiently, and the PIQ-6 provides this ability."

To address this trend, and the common need to measure general health as well, QualityMetric today announces the availability of the SF-12v2(R) Health Survey Pain Enhanced, a combination of the Pain Impact Questionnaire(TM) (PIQ-6(TM)) and SF-12v2(R) Health Survey. "This combined tool offers a unique perspective of patient health not previously available through one tool, and allows for more comprehensive and targeted care," says Jeff Hallowell, Vice President of Business Development at QualityMetric. "The SF-12v2 Pain Enhanced quickly and effectively measures pain severity and impact along with a more comprehensive measure of an individual's functional health and well-being".

The PIQ-6, SF-12v2, and the SF-12v2 Pain Enhanced are available online and in traditional paper and pencil format with fax capability. This fax feature allows the survey data to be collected automatically by simply placing the completed survey into a fax machine. The scanned results are then uploaded into our Smart Measurement(R) System, allowing the results to be collected and scored, with reports available in real time.

To learn more about the SF-12v2 and PIQ-6, please visit: http://www.qualitymetric.com/GenericHealthSurveys.

About QualityMetric Incorporated:

QualityMetric works with the world's largest healthcare and life sciences companies to measure health outcomes. Our products help market new drugs and biologics, track health improvement or decline, screen populations for disease, and identify future health risks. QualityMetric's patient-reported outcome (PRO) surveys provide scientifically valid assessments of both physical and mental health. Our PROs include the SF-36v2(R), SF-12v2(R), and SF-8(TM) Health Surveys, SF-10(TM) Health Survey for Children, Asthma Control Test(TM) (ACT(TM)), Pain Impact Questionnaire(TM) (PIQ-6(TM)), and DYNHA(R) Dynamic Health Assessments. Our Outcomes Insight Consulting(TM) Division can develop customized PROs and provide in-depth analysis of the results. Visit us at www.qualitymetric.com.


'/>"/>
SOURCE QualityMetric Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BurrellesLuce Executive to Speak on Measuring Communications Impact At Joint Seminar of Port-Industry Group and PRSA's Detroit Chapter
2. Researchers compare different systems of measuring treatment intensity in hypertension care
3. Measuring brain atrophy in patients with mild cognitive impairment
4. Tool Shows Promise for Measuring Productivity of Mid-Level Oncology Providers
5. Measuring the impact of electronic medical records
6. New criteria for measuring tumor size and progression will help ease workloads in clinical trials
7. Measuring and Demonstrating the Value of Quality Initiatives
8. Measuring medicine: How new technologies could help doctors predict patient outcomes
9. MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
10. PET Scans Best for Measuring Response to Sarcoma Treatment
11. PDSS reliable in measuring impact of sleep disorders on teens academic performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: